<!DOCTYPE html>
<html lang="en"
>
<head>
    <title>Infinite regress</title>
    <!-- Using the latest rendering mode for IE -->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">



<link rel="canonical" href="http://miljko.org">
        <meta name="author" content="Miloš Miljković" />

    <!-- Enable latex plugin -->


    <!-- Open Graph tags -->
        <meta property="og:site_name" content="Infinite regress" />
        <meta property="og:type" content="website"/>
        <meta property="og:title" content="Infinite regress"/>
        <meta property="og:url" content="http://miljko.org"/>
        <meta property="og:description" content="Infinite regress"/>

    <meta name="twitter:card" content="summary">
        <meta name="twitter:site" content="@miljko">
        <meta name="twitter:creator" content="@miljko">
    <meta name="twitter:domain" content="http://miljko.org">

    <!-- Bootstrap -->
        <link rel="stylesheet" href="http://miljko.org/theme/css/bootstrap.aplan.min.css" type="text/css"/>
    <link href="http://miljko.org/theme/css/font-awesome.min.css" rel="stylesheet">

    <link href="http://miljko.org/theme/css/pygments/native.css" rel="stylesheet">
        <link href="http://miljko.org/theme/css/typogrify.css" rel="stylesheet">
    <link rel="stylesheet" href="http://miljko.org/theme/css/style.css" type="text/css"/>

        <link href="http://miljko.org/rss/index.xml" type="application/rss+xml" rel="alternate"
              title="Infinite regress RSS Feed"/>


    <style type="text/css">
    p {
        margin-top: 18px;
        margin-bottom: 18px;
    }
    </style>

</head>
<body>

<div class="navbar navbar-default navbar-fixed-top" role="navigation">
    <div class="container">
        <div class="navbar-header">
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse">
                <span class="sr-only">Toggle navigation</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
            <a href="http://miljko.org/" class="navbar-brand">
Infinite regress            </a>
        </div>
        <div class="collapse navbar-collapse navbar-ex1-collapse">
            <ul class="nav navbar-nav">
                        <li >
                            <a href="http://miljko.org/category/blog.html">Blog</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/pisanije.html">Pisanije</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/reviews.html">Reviews</a>
                        </li>
            </ul>
            <ul class="nav navbar-nav navbar-right">
                <li><a href="http://miljko.org/archives.html"><i class="fa fa-th-list"></i><span class="icon-label">Archives</span></a></li>
            </ul>
        </div>
        <!-- /.navbar-collapse -->
    </div>
</div> <!-- /.navbar -->

<div class="container">
    <div class="row">
        <div class="col-lg-12">

            <article>
                <h2><a href="http://miljko.org/eng/2014/10/11/stem-cell-transplants-a-slide-show/">Stem cell transplants, a slide&nbsp;show</a></h2>
                <div class="summary"><p>As first-year fellows, we have to present a case at the Medical Oncology Service tumor board every four weeks. Obviously, I can&#8217;t share the details of those talks here. But I <em>can</em> post a sanitized version of my slides, with all identifying information&nbsp;removed.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/10/11/stem-cell-transplants-a-slide-show/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/10/10/pain-and-palliation/">Pain. And&nbsp;Palliation.</a></h2>
                <div class="summary"><p>I am not spiritual, or religious. Living in an atheist country that
suddenly takes a turn towards militant Christian fundamentalism does
that to you. I don&#8217;t believe in woo. I do believe that American doctors
are overtreating their patients&#8217; pain, and that American patients are
too sensitized to it. Yes, the understaffed orthopedic <span class="caps">VA</span> surgery wards
where post-op patients were screaming for their morphine may have led
to the Kabuki of a nurse coming in every couple of hours to ask you
about where your pain is, and what is the <span class="caps">QUALITY</span> of the pain, and
howbadisitfromonetoten? But a cancer center is no <span class="caps">VA</span>. The ritual only
reminds those with chronic cancer pain that yes, it is still there,
and yes, it hurts more than it did 3 hours ago, and now they can&#8217;t
finish reading their book because there is a twinge every couple of
minutes while they are thinking about&nbsp;it.</p>
<p>Which is all a longwinded way of saying that I should not have enjoyed the pain
and pallitavie rotation that much. There is spirituality, there is woo, there is
a lot of pain. And yet I&nbsp;did.</p>
<p>These people know what they are doing. They have plenty of resources
available to do it. And yes, they may &#8220;do Reiki&#8221;—nothing more
than elaborate Kabuki for patients with advanced diseases—but there are
times when that is exactly what the patients need. When 4am vital
signs and checking for hepatomegaly every day just aren&#8217;t&nbsp;enough.</p>
<p>Some useful questions to ask your patients with any serious chronic
disease, if and when you have some extra time in&nbsp;clinic:</p>
<ul>
<li>Are you the same person now as you were before the diagnosis? How did you&nbsp;change?</li>
<li>What do you fear the&nbsp;most?</li>
<li>What do you hope&nbsp;for?</li>
<li>Who(m) do you rely on for support?<sup id="fnref:whom"><a class="footnote-ref" href="#fn:whom" rel="footnote">1</a></sup></li>
</ul>
<p>The patients&#8217; answers may surprise&nbsp;you.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:whom">
<p><span class="dquo">&#8220;</span>Whom&#8221; is gramaticaly correct, but interrpreted as pretentious
by most patients. Use it judiciously. Yes, I realize that what I have
written here is just as bad.&#160;<a class="footnote-backref" href="#fnref:whom" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/10/10/pain-and-palliation/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2014/10/05/peti-oktobar-2014/">Peti oktobar,&nbsp;2014</a></h2>
                <div class="summary"><p><a href="http://miljko.org/srb/2013/10/05/peti-oktobar-2013/">Ovo još uvek važi</a>, uz par
nebitnih izmena i&nbsp;dopuna.</p>
<p><a href="http://www.rasakarapandza.com/random/?p=151">Ovo je još uvek najbolji tekst o petom oktobru koji ćete&nbsp;pročitati.</a></p>
<p>Iz daljine, ne čini mi se da je pravac kojim Srbija ide—ako ga ima—dobar. Isto
mislim i o Americi, ali ona je tanker koji se približava  ledenom bregu. Srbija
je izbušeni splav koji se već&nbsp;prevrnuo.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2014/10/05/peti-oktobar-2014/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2014/10/03/posle-usmle-a-pozivi/">Posle <span class="caps">USMLE</span>-a:&nbsp;pozivi</a></h2>
                <div class="summary"><p>Programi su pre nešto više od dve nedelje počeli da skidaju prijave sa <span class="caps">ERAS</span>-a.
Ako vas je neko već pozvao, čestitam! Ako nije<sup id="fnref:prijava"><a class="footnote-ref" href="#fn:prijava" rel="footnote">1</a></sup>, još nije vreme za
brigu—većina programa pozivnice šalje u talasima, svake dve-tri nedelje, sve do
kraja oktobra-sredine&nbsp;novembra.</p>
<p>Ako vam ni do tada ne stigne ništa, evo šta sigurno ne treba raditi—spemovati
jadne direktore i njihove koordinatore generičkim molbama za intervju.
U najboljem slučaju će ignorisati vaš mejl, u najgorem će vas skinuti sa spiska
potencijalnih kandidata jer ne umete da pratite molbu sa sajta da ih ne
kontaktirate za takve&nbsp;stvari.</p>
<p>Šta onda? Dve stvari: ako znate nekoga ko može garantovati za
vas, zamolite ih da proslede vaše podatke koordinatoru ili direktoru koje
poznaju<sup id="fnref:upozorenje"><a class="footnote-ref" href="#fn:upozorenje" rel="footnote">2</a></sup>; i ako ste
već u Americi, pošaljite mejl okolnim programima da ste dostupni u kratkom roku,
za slučaj da neki kandidat otkaže razgovor dan-dva pre. Za tako nešto je dobro biti
u mestima sa visokom koncentracijom programa koji primaju strance (čitaj: Istočna obala, Čikago).
Naravno, prijavite se na te programa preko <span class="caps">ERAS</span>-a <em>pre</em> slanja&nbsp;mejla.</p>
<p>Ako ste završili sve stepove ali još niste dobili <span class="caps">ECFMG</span> sertifikat,
slobodno se prijavite—programi to obično gledaju tek kad dođe vreme za
rangiranje. Ako već morate da se prijavite bez svih stepova, Step 2 <span class="caps">CK</span>
je najmanje bitan. <span class="caps">CS</span> je i dalje najlakši za prolaz, ali je njegovo
padanje najveća crvena zastava koju nečija aplikacija može imati, tako da se
stranci bez položenog <span class="caps">CS</span>-a obično ne&nbsp;pozivaju.</p>
<p>Sledeća bitna stavka su pisma preporuke. Nema svrhe plaćati prijavu za
program koji na sajtu traži četiri pisma, a vi to četvrto još čekate.
Srećom, većina je <span class="caps">OK</span> i sa tri, dok se poslednje može dodati naknadno.
<span class="caps">MSPE</span> (&#8220;dekanovo pismo&#8221;) i transkript su neophodni, ali za strane
kandidate nebitni pošto sistemi ocenjivanja nisu uporedivi. Na žalost,
to je još jedna stavka za koju morati čekati na šalterima, hodnicima
fakulteta,&nbsp;itd.</p>
<p>Srećno!</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:prijava">
<p>Ili ako još niste poslali prijavu, u kom slučaju, šta kog
đavola čekate‽&#160;<a class="footnote-backref" href="#fnref:prijava" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
<li id="fn:upozorenje">
<p>Upozorenje: morate biti sigurni da su u
dobrim odnosima. Postoje ljudi čija bi preporuka bila garancija za brisanje sa
liste.&#160;<a class="footnote-backref" href="#fnref:upozorenje" rev="footnote" title="Jump back to footnote 2 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2014/10/03/posle-usmle-a-pozivi/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/21/its-well-known-that-most-common-knowledge-is-false/">It’s well-known that most common knowledge is&nbsp;false</a></h2>
                <div class="summary"><p>Did you hear the one about not prescribing angiotensin receptor blockers to
patients with <span class="caps">ACE</span> inhibitor-induced angioedema? I&#8217;ve had heated debates
with residents in my old clinic who did not want to even consider ARBs for
a patient with worsening diabetic nephropathy who&#8217;s had lip swelling
while on an <span class="caps">ACE</span>-I <em>ten years ago</em>.</p>
<p>Or the one about not giving these patients amlodipine, since there
are two—<a href="http://www.ncbi.nlm.nih.gov/pubmed/19299323">yes</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/21330681">two</a>—case reports on amlodipine-associated
angioedema? Should we also stop giving them <a href="http://www.ncbi.nlm.nih.gov/pubmed/15120149">water</a>?</p>
<p>Then there are shellfish allergies and iodine contrast, fever and
atelectasis, morbid obesity and hypothyroidism… No matter how many
studies show these associations to be too weak to be clinicaly
significant, or just plain false, there will always be an attending
somewhere giving them as his or her pearl of the&nbsp;day.</p>
<p>We need some <a href="http://www.bmj.com/content/335/7633/1288">medical mythbusting</a> for physicians, not just the lay&nbsp;public.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/21/its-well-known-that-most-common-knowledge-is-false/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/21/how-to-spend-a-monday-morning-train-ride/">How to spend a Monday morning train&nbsp;ride</a></h2>
                <div class="summary"><ul>
<li><a href="http://calnewport.com/blog/2014/08/08/deep-habits-plan-your-week-in-advance/">Deep Habits: Plan Your Week in&nbsp;Advance</a></li>
<li><a href="http://calnewport.com/blog/2014/09/09/deep-habits-when-the-going-gets-tough-build-a-temporary-plan/">Deep Habits: When the Going Gets Tough, Build a Temporary&nbsp;Plan</a></li>
</ul>
<p>The <a href="http://zenhabits.net/weekly-review-key-to-gtd-and-achieving/"><span class="caps">GTD</span> weekly review</a> does a good of job keeping my task list
managable, but not all tasks and projects are equal. It&#8217;s good to have
a sense of when you might have time for deep thinking versus mindless
task processing&#8212;-something <span class="caps">GTD</span> doesn&#8217;t trully account for. I had been doing a
variant of weekly planning since high school, until internship destroyed
any hope of having a <em>daily</em>, let alone weekly plan. It&#8217;s time to start&nbsp;again.</p>
<p>And if you are not following <a href="http://calnewport.com/blog/">Cal Newport&#8217;s blog</a> already, you should. The man is
a&nbsp;machine.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/21/how-to-spend-a-monday-morning-train-ride/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/14/no-theres-nothing-wrong-with-your-attention-span/">No, there&#8217;s nothing wrong with your attention&nbsp;span</a></h2>
                <div class="summary"><p>After skimming through the fifth long-form article about the increase in
bite-sized consumable writing made for the short-attention-span&#8212;-dare
I say &#8220;millennial&#8221;&#8212;-crowd, I became scared for my own tenacity. Would
the 15-year-old me, the one who had read the LotR cover to cover, be
horrified by this balding humunculus with twice the age and&#8212;-if you&#8217;d believe
the articles&#8212;-half the attention&nbsp;span?</p>
<p>No, he would not. I can write that with confidence of a man who has just burned
through the first two <a href="https://en.wikipedia.org/wiki/The_Dark_Tower_(series)">Dark Tower</a> books exclusively while riding the
subway. Get in at Union Station, actually sit down to read at Gallery Place,
blink and I&#8217;m done with a chapter or two and arriving at&nbsp;Bethesda.</p>
<p>Stephen King is a hell of a writer, you see, and most of what you can find
online&#8212;-this blog post included&#8212;-is derivative crap at worst, well-written
nonsense at best. My brain jumping from text to text was its way of saying <em>Dude,
why are you punishing me with this drivel? Just get us a good book</em>. So I did,
and the percieved length of my metro commute has decreased by two orders of
magnitude. Which is a convoluted way of saying that time flies when you&#8217;re
having fun<sup id="fnref:crap"><a class="footnote-ref" href="#fn:crap" rel="footnote">1</a></sup>.</p>
<p>But if you&#8217;ve never read a book in your life and are now devouring Buzzfeed like
a horsefly in a manure factory&#8212;-sorry, there is no help. It <em>is</em>&nbsp;you.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:crap">
<p>See above re: quality of online writing.&#160;<a class="footnote-backref" href="#fnref:crap" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/14/no-theres-nothing-wrong-with-your-attention-span/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/12/which-opioids-are-safe-in-kidney-and-liver-failure/">Which opioids are safe in kidney and liver&nbsp;failure?</a></h2>
                <div class="summary"><p>Many times during residency I looked for a table like this online. There weren&#8217;t
any, so I decided to create&nbsp;one.</p>
<p><img src="/images/opioid-safety@2x.png" width="320px" height="421px" /></p>
<p>Ye&#8217;r&nbsp;welcome.</p>
<p><em>Source: Induru <span class="caps">RR</span>, et al. Managing Cancer Pain: Frequently Asked
Questions. Cleveland Clinic Journal Of Medicine.&nbsp;2011;78(7).</em></p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/12/which-opioids-are-safe-in-kidney-and-liver-failure/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/06/what-i-learned-and-unlearned-on-bone-marrow-transplants/">What I learned and unlearned on bone marrow&nbsp;transplants</a></h2>
                <div class="summary"><p>The average heme/onc fellowship program doesn&#8217;t have many &#8220;tough&#8221;
rotations. The one that is universally feared is the erroneously
named Bone marrow transplant service<sup id="fnref:bmt"><a class="footnote-ref" href="#fn:bmt" rel="footnote">2</a></sup>. After spending six weeks
on such rotation fresh out of (Chief) residency, I think I can
understand&#8212;-though not agree with&#8212;-the reasons&nbsp;why.</p>
<p>It is not easy. The patients are either already, or about to become,
extraordinarily sick, with little outward signs or symptoms to show
it. Having cancer while not having an immune system is not a good
combination, even if it is temporary. The ones who are months or years
out from a successful transplant and still need to be hospitalized
are usually miserable from longstanding severe graft versus host
disease<sup id="fnref:bias"><a class="footnote-ref" href="#fn:bias" rel="footnote">1</a></sup>. It makes for a tough bunch of humans to deal with&nbsp;day-to-day.</p>
<p>Then again, being on transplant service in an academic center can be the
apex of your inpatient career. Months of residency spent on acute care
floors and in intensive care units should have given you all the skills
you need to do well. These are, in no particular&nbsp;order:</p>
<ul>
<li><em>Clarifying ambiguity</em>: The rounds are over, attendings and consultants have
  dispersed, and you have just heard more facts about T-cell activation than you
  realized existed. But&#8212;-do you know if that febrile-but-not-neutropenic patient
  should get an antibiotic? What&#8217;s that other patient&#8217;s target Tacro
  level? Send <span class="caps">CSF</span> for flow, or just give intrathecal Methotrexate? If those
  aren&#8217;t clear, you should have asked more questions, and not of the &#8220;Which cells
  have <span class="caps">IL</span>-6 receptors?&#8221;&nbsp;kind.</li>
<li><em>Identify attending priority</em>: This is often the biggest cause of ambiguity.
  Between the floor attending, the study <span class="caps">PI</span>, staff <span class="caps">ID</span> consultant, and various other
  consulting services, whose advice do you heed? Not always the same person&#8217;s,
  and not even in the same order. Not much you can do, except be aware of it,
  and not follow everyone&#8217;s advice as soon as you hear&nbsp;it.</li>
<li><em>Asserting your autonomy</em>: With all this asking and following, you may rightly ask
  if you were anything more than a glorified intern. In the field of
  hematology, oncology, and infections that affect this population, you most
  certainly are&#8212;-you are, after all, still in training. Not so for most other
  matters of internal medicine. Blood pressures, fingerstick, <span class="caps">TSH</span> levels&#8212;-if
  you are comfortable managing them, let the team&nbsp;know.</li>
<li><em>Being there early</em>: An important trait often forgotten by senior <span class="caps">IM</span> residents.
  Just getting there an hour earlier than anyone else to get the work done makes
  you look like a superstar. One hour in the early morning save three in the late&nbsp;afternoon.</li>
<li><em>Dictating right away</em>: Like, pronto. The answer to &#8220;How many pending
  dictations do you have&#8221; should always be &#8220;Zero&#8221;. It&#8217;s easier for you, and is
  just good patient care. No&nbsp;excuses.</li>
<li><em>Writing everything down</em>: This is How to be an intern 101, but being at least two
  years removed from internship can make you stupid. Carry the patient list and
  <a href="http://www.jetpens.com/Zebra-Sarasa-Push-Clip-Gel-Ink-Pen-0.4-mm-Black/pd/797">a good pen</a> with you at all times. Yes, that includes the&nbsp;restroom.</li>
</ul>
<p>Nothing here is particular to transplants&#8212;-it is just good inpatient
medicine. Which may be why so many oncology fellows loathe it&#8212;-it is,
after all, an outpatient specialty. Then again, stem cell transplants
are one of the few therapies we have that can cure&nbsp;cancer.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:bias">
<p>Which is not to say that <em>everyone</em> who had a stem cell transplant is
miserable&#8212;-a mistaken belief many oncology fellows have after the rotation, and
a clear example of selection bias.&#160;<a class="footnote-backref" href="#fnref:bias" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
<li id="fn:bmt">
<p>Most stem cells used for transplants are now harvested from the
peripheral blood, not the bone marrow.&#160;<a class="footnote-backref" href="#fnref:bmt" rev="footnote" title="Jump back to footnote 2 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/06/what-i-learned-and-unlearned-on-bone-marrow-transplants/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/08/22/what-is-the-evidence-for-that/">What is the evidence for&nbsp;that?</a></h2>
                <div class="summary"><p>This has become the mantra of every medical student, intern, and
resident wanting to appear smart on rounds and conferences, of every
attending intent on shooting down a team member&#8217;s suggestion. Five,
ten years ago it might have have signaled genuine interest. Now
it means, usually, &#8220;I don&#8217;t know anything about the subject, but I&#8217;m
still calling you out on (what I think is) your <span class="caps">BS</span>. Here, look at me! I am&nbsp;evidence-based!&#8221;</p>
<p>No, nobody has posed me that question in quite a while, and I don&#8217;t
remember ever asking it in any context<sup id="fnref:questions"><a class="footnote-ref" href="#fn:questions" rel="footnote">1</a></sup>. But, honestly,
except for a few <a href="http://www.medrants.com/archives/7842">very well-known examples listed in this excellent
post</a>, you can find &#8220;evidence&#8221; in the medical
literature to back up any claim. Off-the-cuff conversations during
lectures and rounds are not the best place to dissect them, especially
when one side has&nbsp;seniority.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:questions">
<p>Although I understand asking questions means showing
interest, I&#8217;ve always preferred looking things up myself. This would
make me appear either very smart or very dumb, depending on whatever
subcontious impression I made on the person in the first few minutes of
us meeting. Try to use the halo effect to your advantage.&#160;<a class="footnote-backref" href="#fnref:questions" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/08/22/what-is-the-evidence-for-that/">more ...</a>
                </div>
            </article>
            <hr/>

        <ul class="pagination">
                <li class="prev"><a href="http://miljko.org/index9.html">&laquo;</a>
                </li>
                    <li class=""><a
                            href="http://miljko.org/index.html">1</a></li>
                    <li class=""><a
                            href="http://miljko.org/index2.html">2</a></li>
                    <li class=""><a
                            href="http://miljko.org/index3.html">3</a></li>
                    <li class=""><a
                            href="http://miljko.org/index4.html">4</a></li>
                    <li class=""><a
                            href="http://miljko.org/index5.html">5</a></li>
                    <li class=""><a
                            href="http://miljko.org/index6.html">6</a></li>
                    <li class=""><a
                            href="http://miljko.org/index7.html">7</a></li>
                    <li class=""><a
                            href="http://miljko.org/index8.html">8</a></li>
                    <li class=""><a
                            href="http://miljko.org/index9.html">9</a></li>
                    <li class="active"><a
                            href="http://miljko.org/index10.html">10</a></li>
                    <li class=""><a
                            href="http://miljko.org/index11.html">11</a></li>
                    <li class=""><a
                            href="http://miljko.org/index12.html">12</a></li>
                    <li class=""><a
                            href="http://miljko.org/index13.html">13</a></li>
                    <li class=""><a
                            href="http://miljko.org/index14.html">14</a></li>
                    <li class=""><a
                            href="http://miljko.org/index15.html">15</a></li>
                <li class="next"><a
                        href="http://miljko.org/index11.html">&raquo;</a></li>
        </ul>
        </div>
    </div>
</div>
<footer>
   <div class="container">
      <hr>
       <div class="row">
        <div class="col-xs-12" id="aboutme">
<p>
    <strong>About Miloš Miljković</strong><br/>
    <p>Hematologist/medical oncologist caring for patients with T-cell malignancies and relapsed solid tumors at the <a href="http://cancer.gov">National Cancer Institute</a> in Bethesda, Maryland.<p><a href="https://twitter.com/miljko">@miljko</a> on Twitter.
</p>        </div>
       </div>
      <hr>
      <div class="row">
         <div class="col-xs-10">&copy; 2018 Miloš Miljković
            &middot; Powered by <a href="http://docs.getpelican.com/" target="_blank">Pelican</a>,
            <a href="http://getbootstrap.com" target="_blank">Bootstrap</a>         </div>
         <div class="col-xs-2"><p class="pull-right"><i class="fa fa-arrow-up"></i> <a href="#">Top</a></p></div>
      </div>
   </div>
</footer>
<script src="http://miljko.org/theme/js/jquery.min.js"></script>

<!-- Include all compiled plugins (below), or include individual files as needed -->
<script src="http://miljko.org/theme/js/bootstrap.min.js"></script>

<!-- Enable responsive features in IE8 with Respond.js (https://github.com/scottjehl/Respond) -->
<script src="http://miljko.org/theme/js/respond.min.js"></script>

</body>
</html>